USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis
Cells · 08.06.2023 · 12 (12) · 1585
DOI: 10.3390/cells12121585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 08.06.2023. Verfasst von Kateryna Kubaichuk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biochemistry and Molecular Biology, University of Oulu, 90570 Oulu, Finland. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oulu, Sigrid Jusélius Foundation, EDUFI Fellowship.
Abstract (Originalsprache)
Colorectal cancer ranks among the third most common human malignant diseases and is one of the leading causes of cancer-related deaths globally. Colon cancer cells are hypoxic and display disturbed protein homeostasis. Ubiquitin-ligase-initiated proteasomal degradation as well as its prevention by deubiquitinases (DUBs) are supposed to contribute to the above-mentioned disturbances. However, not much is known about the involvement of ubiquitinating and deubiquitinating enzymes in colon cancer and their effect on the hypoxia response. Here, we identify the DUB ubiquitin-specific protease 10 (USP10) as an important player in the control of colon cancer progression and a new modifier of the hypoxia response. Mechanistically, we show that knockout of USP10 in different colon cancer cells causes an elevation in HIF-1α but not HIF-2α protein levels under both normoxic and hypoxic conditions. In addition, the lack of USP10 increased cellular migration, reduced cell adhesion, and switched the energy phenotype towards increased glycolysis and enhanced extracellular acidification. These changes were at least partially caused by HIF-1α, as the knockdown of HIF-1α rescued the cellular phenotype caused by USP10 deficiency. Interestingly, the USP10-dependent increase in HIF-1 α was neither caused by enhanced transcription nor prolonged half-life but via mTOR/S6K mediated HIF-1α protein synthesis. Together, the current findings indicate that USP10 is able to participate in colon carcinogenesis by modulating the hypoxia response and may therefore represent a new therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biochemistry and Molecular Biology, University of Oulu, 90570 Oulu, Finland.
ORCID-Profile: Thomas Kietzmann
Förderung
- University of Oulu
- Sigrid Jusélius Foundation
- EDUFI Fellowship
- Biocenter Oulu (BCO)
Zitieren
APA
Kubaichuk, K., & Kietzmann, T. (2023). USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis. Cells, 12(12), 1585. https://doi.org/10.3390/cells12121585
Vancouver
Kubaichuk K, Kietzmann T. USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis. Cells. 2023;12(12):1585. doi:10.3390/cells12121585
BibTeX
@article{Kubaichuk2023,
author = {Kubaichuk, Kateryna and Kietzmann, Thomas},
title = {USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis},
journal = {Cells},
year = {2023},
volume = {12},
number = {12},
pages = {1585},
doi = {10.3390/cells12121585}
}
EUVIMED